SIL KASALLIGI (TUBERKULYOZ) — SABABLARI, ALOMATLARI, DAVOLASH VA OLDINI OLISH

Zenodo (CERN European Organization for Nuclear Research) 2026 Dataset Open access

Read full text
Authors: Shodmonova Mohlaroy Zafarbek qizi, Worldly Knowledge Publishing Centre
DOI: 10.5281/zenodo.18645917
Cited by: 0

Abstract

Mazkur maqolada sil kasalligining (tuberkulyoz) etiologiyasi, epidemiologiyasi, patogenezi, klinik belgilari, zamonaviy diagnostika usullari, davolash tamoyillari hamda profilaktika choralari xalqaro va milliy manbalar asosida tahlil qilinadi. Jahon sog‘liqni saqlash tashkiloti (JSST) ma’lumotlariga ko‘ra, 2022-yilda dunyoda 10,6 million yangi sil kasalligi holati qayd etilgan va 1,3 million kishi sil tufayli vafot etgan [1]. Maqolada Mycobacterium tuberculosis etiologik omil sifatida, yuqish yo‘llari, xavf omillari, ko‘p dori vositalariga chidamli shakllar (MDR-TB), DOTS strategiyasi va BCG vaksinasining roli ilmiy manbalar asosida yoritilgan.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis Diagnosis and treatment of tuberculosis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
15 February 2026
Document type
Dataset